Optimizing patient access for novel stem cell therapy
Understand the Funds Flow at national and local level for a haematopoietic stem cell (HSC) therapy in terms of processes, stakeholders and data requirements in order to accelerate the preparation for the launch of the HSC therapy through the definition of a targeted action plan to ensure optimal access.
Current fund flow
Analyze funds flow for stem cell therapy through primary market research
Learn from a Stem Cell analogues
Define strategic implications & recommendations
Derived strategic implications for the preparation of successful HSC therapy patient access
Defined the optimal funding scenario for HSC therapy and recommendations on strategies and key actions to maximize optimal patient access likelihood